tirofiban has been researched along with Brain Hemorrhage in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (6.06) | 29.6817 |
| 2010's | 12 (36.36) | 24.3611 |
| 2020's | 19 (57.58) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, T; Liu, X; Wu, N; Zhang, A | 1 |
| Hang, Y; Jia, ZY; Liu, S; Ni, H; Shi, HB; Wang, CD; Zhao, LB | 1 |
| Huang, S; Liang, Z; Xiang, W; Xu, L; Yang, S; Zhang, J; Zhang, M | 1 |
| Bai, Y; Cao, W; Chang, M; Chen, S; Dai, W; Deng, W; Du, J; Fu, X; Ge, H; Guo, F; Guo, Z; Hong, Y; Hu, J; Hu, W; Hu, Z; Huang, C; Huang, J; Huang, W; Huang, X; Jiang, S; Jin, Y; Jin, Z; Ju, D; Ke, Y; Kong, W; Lei, B; Li, F; Li, H; Li, J; Li, L; Li, R; Liu, S; Liu, T; Liu, W; Long, C; Lu, M; Luo, J; Luo, S; Luo, W; Luo, X; Miao, J; Nogueira, RG; Pan, C; Peng, D; Pu, J; Qi, L; Qiu, Z; Sang, H; Saver, JL; Shi, Z; Song, B; Song, J; Sun, D; Sun, Y; Tian, Y; Tian, Z; Wan, Y; Wang, J; Wang, L; Wang, S; Wang, T; Wang, Y; Wei, L; Wen, C; Wen, H; Wu, D; Wu, J; Wu, Y; Xu, X; Yan, Z; Yang, J; Yang, Q; Yang, S; Yu, Y; Yuan, G; Yuan, J; Yuan, Z; Yue, C; Zeng, G; Zeng, H; Zhang, G; Zhang, J; Zhang, M; Zhang, S; Zhao, W; Zheng, B; Zheng, C; Zhou, P; Zhou, Z; Zhu, X; Zi, W | 1 |
| Chen, J; Duan, J; Guo, W; Ji, X; Li, C; Li, S; Ma, J; Ma, L; Ma, Q; Ren, C; Song, H; Wu, C; Wu, L; Xu, J; Zhao, W | 1 |
| Chen, S; Deng, S; Li, T; Lin, B; Liu, Q; Lu, X; Pan, L; Peng, R; Shi, S; Weng, B; Xun, W; Yang, H; Zhang, J | 1 |
| Chen, Q; Dai, W; Deng, W; Feng, X; Fu, Y; Han, Q; Hu, J; Huang, X; Meng, R; Qiu, Z; Sang, H; Tao, Z; Tian, Y; Wang, T; Wu, D; Xie, D; Yuan, J; Zhang, M; Zuo, L | 1 |
| He, ZF; Hou, MM; Li, XY; Liu, XL; Ren, G; Shi, H; Sun, B | 1 |
| Abdalkader, M; Du, J; Gu, G; Guo, Q; Han, Q; Hu, J; Hu, X; Huang, C; Huang, J; Jiang, B; Jin, Y; Li, F; Liu, S; Liu, T; Luo, S; Mao, A; Nguyen, TN; Pu, J; Qiu, Z; Sang, H; Tao, Z; Wang, L; Yan, Z; Yang, J; Zhao, W; Zhou, S; Zi, W | 1 |
| Li, G; Liu, C; Liu, M; Wang, J; Yang, X | 2 |
| Cai, T; Cao, M; Chen, X; Chen, Z; Cheng, D; Geng, W; Guo, C; He, P; He, W; Hu, J; Huang, F; Huang, J; Huang, W; Huang, X; Kong, W; Li, B; Li, F; Li, H; Li, L; Li, Z; Liang, H; Liu, C; Liu, J; Liu, S; Liu, W; Liu, Z; Luo, J; Miao, J; Mu, J; Nogueira, RG; Peng, Y; Qiu, Z; Saver, JL; Shi, Q; Shi, Z; Song, J; Tan, X; Tang, M; Tang, Y; Tian, Y; Wan, Y; Wang, D; Wang, M; Wang, P; Wu, Y; Xie, S; Xie, W; Yang, D; Yang, J; Yang, Q; Yang, S; Yao, L; Yu, Y; Yu, Z; Yue, C; Zhang, B; Zhao, H; Zheng, J; Zi, W | 1 |
| Al-Jebur, MS; Al-Salihi, MM; Al-Salihi, Y; Ayyad, A; Kasab, SA; Kass-Hout, T; Morsi, RZ; Saha, R; Spiotta, AM | 1 |
| Guo, C; Hu, J; Huang, J; Kong, W; Li, F; Li, L; Liu, C; Liu, X; Miao, J; Peng, Z; Saver, JL; Song, J; Tian, Y; Yang, D; Yang, J; Yue, C; Zhang, X; Zi, W | 1 |
| Gao, L; Guo, Z; Jiang, J; Li, F; Long, T; Luo, Y; Lv, Z; Meng, R; Qiu, Z; Rong, B; Tian, J; Xie, Y; Yang, Y; Yuan, Z; Zeng, H; Zhang, S; Zhao, J; Zi, W | 1 |
| Ding, J; Huang, S; Ji, X; Lian, Y; Ma, Q; Ren, M; Song, H; Sun, C; Wang, L; Wang, Y; Wu, C; Wu, D; Xie, N; Zhao, W | 1 |
| Gong, J; Liu, G; Shang, J; Su, D; Sun, Z; Wan, Q; Yu, H | 1 |
| Guo, Y; Li, H; Shen, J; Wang, R; Wang, Y; Yao, Q; Yu, X; Zhang, P | 1 |
| Cao, W; Dong, Q; Feng, Y; Ling, Y; Mao, Y; Rong, X; Wang, Z; Zhao, H | 1 |
| Chen, C; Hu, W; Liu, D; Liu, J; Liu, T; Luo, W; Song, J; Tao, C; Yuan, X; Zhang, C; Zhu, Y | 1 |
| Ballotta, E; Baracchini, C; Causin, F; Cester, G; Farina, F; Favaretto, S; Kulyk, C; Nico, L; Palmieri, A; Soso, M; Viaro, F | 1 |
| Jiang, L; Lin, L; Parsons, MW; Wu, Y; Yang, J; Yin, C | 1 |
| Bai, Y; Fan, X; Hao, Y; Li, S; Li, Z; Liu, X; Sun, B; Tian, X; Wang, H; Xu, G; Yang, D; Zhang, M; Zhang, S; Zhang, X; Zi, W | 1 |
| Chen, TW; Huang, H; Jiang, L; Liu, KQ; Sang, HF; Si, XL; Xia, WQ; Yin, CG | 1 |
| Guo, Y; Lin, Y; Pan, X; Tang, Q; Tang, Y; Wang, X; Yang, J; Zou, J | 1 |
| Bae, HJ; Chung, JW; Han, MK; Jang, MS; Jung, C; Kim, JH; Kim, KJ; Kwon, OK; Lee, J; Lee, JS; Noh, WY; Oh, CW; Yang, MH | 1 |
| Abraha, I; Ciccone, A; Cozzolino, F; Motto, C; Santilli, I | 1 |
| Chalouhi, N; Daou, B; Hasan, DM; Jabbour, P; Shields, B; Starke, RM | 1 |
| Boiti, C; Borutti, G; Cazzaniga, M; Falaschi, F; Maestroni, A; Mandelli, C; Manganaro, D; Monzani, V; Rossi, P; Torgano, G; Zecca, B; Zilioli, E | 1 |
| Fiebach, JB; Hamann, G; Hennerici, MG; Junghans, U; Röther, J; Schneider, D; Seitz, RJ; Siebler, M; Villringer, A; von Reutern, GM; Witte, OW | 1 |
| Bang, OY; Byun, HS; Jeon, P; Kim, GM; Kim, JW; Kim, KH | 1 |
| Cellerini, M; Gensini, G; Inzitari, D; Mangiafico, S; Nencini, P | 1 |
| Blankenship, JC; Frey, CM; Memon, MA; Menapace, FJ; Wood, GC | 1 |
12 review(s) available for tirofiban and Brain Hemorrhage
| Article | Year |
|---|---|
Continuous intravenous tirofiban can improve the 90-day functional outcome and decrease 90-day mortality without increasing bleeding risk in acute ischemic stroke patients treated by endovascular therapy: A meta-analysis.
Topics: Administration, Intravenous; Cohort Studies; Endovascular Procedures; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Thrombolytic Therapy; Tirofiban; Treatment Outcome | 2022 |
Early tirofiban administration for patients with acute ischemic stroke treated with intravenous thrombolysis or bridging therapy: Systematic review and meta-analysis.
Topics: Administration, Intravenous; Brain Ischemia; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Stroke; Thrombectomy; Thrombolytic Therapy; Tirofiban; Treatment Outcome | 2022 |
Tirofiban for Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis: A Systematic Review and Meta-Analysis.
Topics: Brain Ischemia; Endovascular Procedures; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Stroke; Thrombectomy; Thrombolytic Therapy; Tirofiban; Treatment Outcome | 2023 |
Meta-analysis of the efficacy and safety of tirofiban in patients with acute ischaemic stroke undergoing mechanical thrombectomy.
Topics: Brain Ischemia; Humans; Intracranial Hemorrhages; Ischemic Stroke; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2023 |
Safety and efficacy of tirofiban in the management of stroke: A systematic review and meta-analysis of randomized controlled trials.
Topics: Brain Ischemia; Humans; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Tirofiban; Treatment Outcome | 2023 |
Systematic review and meta-analysis of the efficacy and safety of adjunctive use of tirofiban in patients treated with endovascular therapy for acute ischemic stroke at different embolic sites.
Topics: Brain Ischemia; Endovascular Procedures; Humans; Intracranial Hemorrhages; Ischemic Stroke; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2023 |
Tirofiban for acute ischemic stroke: systematic review and meta-analysis.
Topics: Brain Ischemia; Humans; Injections, Intra-Arterial; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Tirofiban; Treatment Outcome | 2020 |
Efficacy and safety of tirofiban therapy in patients receiving endovascular treatment after large vessel ischaemic stroke: A systematic review and meta-analysis.
Topics: Aged; Combined Modality Therapy; Endovascular Procedures; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Male; Middle Aged; Tirofiban; Treatment Outcome | 2020 |
Sequential tirofiban infusions combined with endovascular treatment may improve outcomes in acute ischemic stroke - a meta-analysis.
Topics: Endovascular Procedures; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Tirofiban; Treatment Outcome | 2021 |
Safety and efficacy of early antiplatelet therapy in acute ischemic stroke patients receiving endovascular treatment: A systematic review and meta-analysis.
Topics: Brain Ischemia; Endovascular Procedures; Humans; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Thrombolytic Therapy; Tirofiban; Treatment Outcome | 2019 |
Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke.
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Brain Ischemia; Humans; Immunoglobulin Fab Fragments; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Stroke; Tirofiban; Tyrosine | 2014 |
Incidence of intracranial hemorrhage complicating treatment with glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis of major clinical trials.
Topics: Abciximab; Acetates; Acute Disease; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Coronary Disease; Drug Therapy, Combination; Eptifibatide; Heparin; Humans; Immunoglobulin Fab Fragments; Incidence; Infusions, Intravenous; Intracranial Hemorrhages; Odds Ratio; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Syndrome; Tirofiban; Tyrosine | 2000 |
8 trial(s) available for tirofiban and Brain Hemorrhage
| Article | Year |
|---|---|
Safety and efficacy of low-dose rt-PA with tirofiban to treat acute non-cardiogenic stroke: a single-center randomized controlled study.
Topics: Brain Ischemia; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Prospective Studies; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome | 2022 |
Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion Stroke: The RESCUE BT Randomized Clinical Trial.
Topics: Administration, Intravenous; Aged; Arterial Occlusive Diseases; Brain Ischemia; Double-Blind Method; Endovascular Procedures; Female; Humans; Intracranial Hemorrhages; Ischemic Stroke; Male; Platelet Aggregation Inhibitors; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2022 |
Association between intravenous tirofiban and intracranial hemorrhage in acute large vessel occlusion stroke: insight from the RESCUE BT randomized placebo-controlled trial.
Topics: Aged; Brain Ischemia; Endovascular Procedures; Humans; Intracranial Hemorrhages; Ischemic Stroke; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2023 |
Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion.
Topics: Aspirin; Brain Ischemia; Cerebral Arterial Diseases; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Platelet Aggregation Inhibitors; Tirofiban; Treatment Outcome | 2023 |
Intravenous tirofiban following successful reperfusion in intracranial large artery atherosclerotic stroke: A secondary analysis of a randomized clinical trial.
Topics: Arteries; Brain Ischemia; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Reperfusion; Stroke; Tirofiban; Treatment Outcome | 2023 |
Association of tirofiban treatment with outcomes following endovascular therapy in cardioembolic stroke: insights from the RESCUE BT randomized trial.
Topics: Brain Ischemia; Embolic Stroke; Endovascular Procedures; Humans; Intracranial Hemorrhages; Stroke; Tirofiban; Treatment Outcome | 2023 |
Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Chi-Square Distribution; Disability Evaluation; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Early Termination of Clinical Trials; Female; Fibrinolytic Agents; Hospital Mortality; Humans; Intracranial Hemorrhages; Italy; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recovery of Function; Stroke; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2010 |
Safety of Tirofiban in acute Ischemic Stroke: the SaTIS trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Ischemia; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Radiography; Stroke; Time Factors; Tirofiban; Tyrosine | 2011 |
13 other study(ies) available for tirofiban and Brain Hemorrhage
| Article | Year |
|---|---|
Balloon Angioplasty Combined with Tirofiban as a First-Line Rescue Treatment After Failed Mechanical Thrombectomy for Middle Cerebral Artery Occlusion with Underlying Atherosclerosis.
Topics: Angioplasty; Angioplasty, Balloon; Atherosclerosis; Constriction, Pathologic; Humans; Infarction, Middle Cerebral Artery; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2022 |
Safety and efficacy of different tirofiban administration routes on acute ischemic stroke patients with successful recanalization: A propensity score matching analysis.
Topics: Brain Ischemia; Cohort Studies; Humans; Intracranial Hemorrhages; Ischemic Stroke; Propensity Score; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome | 2022 |
Association of Intravenous Tirofiban with Functional Outcomes in Acute Ischemic Stroke Patients with Acute Basilar Artery Occlusion Receiving Endovascular Thrombectomy.
Topics: Basilar Artery; Humans; Intracranial Hemorrhages; Ischemic Stroke; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2023 |
Low-Dose Tirofiban Treatment Improves Neurological Deterioration Outcome After Intravenous Thrombolysis.
Topics: Aged; Disease Progression; Female; Fibrinolytic Agents; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Mortality; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome | 2019 |
Association between tirofiban monotherapy and efficacy and safety in acute ischemic stroke.
Topics: Aspirin; China; Clopidogrel; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Prospective Studies; Tirofiban | 2021 |
Stentriever Thrombectomy Failure: A Challenge in Stroke Management.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Carotid Artery Diseases; Cerebral Angiography; Computed Tomography Angiography; Endovascular Procedures; Female; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; Infusions, Intra-Arterial; Intracranial Hemorrhages; Magnetic Resonance Angiography; Male; Middle Aged; Mortality; Prospective Studies; Stents; Stroke; Thrombectomy; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Failure; Treatment Outcome; Tyrosine; Ultrasonography, Doppler, Transcranial | 2017 |
Endovascular Thrombectomy.
Topics: Aged; Aged, 80 and over; Endovascular Procedures; Female; Fibrinolytic Agents; Humans; Injections, Intra-Arterial; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Postoperative Hemorrhage; Prospective Studies; Stroke; Thrombectomy; Tirofiban | 2018 |
Safety of Intra-Arterial Tirofiban Administration in Ischemic Stroke Patients after Unsuccessful Mechanical Thrombectomy.
Topics: Aged; Brain Ischemia; China; Female; Fibrinolytic Agents; Humans; Injections, Intra-Arterial; Intracranial Hemorrhages; Male; Middle Aged; Recovery of Function; Registries; Retrospective Studies; Risk Factors; Stroke; Thrombectomy; Thrombolytic Therapy; Time Factors; Tirofiban; Treatment Outcome | 2019 |
Mechanical Thrombectomy Using Solitaire in Acute Ischemic Stroke Patients with Vertebrobasilar Occlusion: A Prospective Observational Study.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Multivariate Analysis; Postoperative Hemorrhage; Prognosis; Prospective Studies; Stroke; Thrombectomy; Time-to-Treatment; Tirofiban; Tomography, X-Ray Computed; Vertebrobasilar Insufficiency | 2019 |
Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Topics: Abciximab; Aged; Antibodies, Monoclonal; Atrial Fibrillation; Brain Ischemia; Combined Modality Therapy; Comorbidity; Female; Fibrinolytic Agents; Humans; Hypertension; Immunoglobulin Fab Fragments; Infusions, Intra-Arterial; Infusions, Intravenous; Intracranial Hemorrhages; Magnetic Resonance Imaging; Male; Mechanical Thrombolysis; Middle Aged; Neuroimaging; Prognosis; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Single-Blind Method; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator | 2013 |
A New Protocol for Anticoagulation With Tirofiban During Flow Diversion.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clinical Protocols; Clopidogrel; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Intracranial Aneurysm; Intracranial Hemorrhages; Intraoperative Care; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Tirofiban; Tyrosine | 2016 |
Local intraarterial tirofiban after formation of anterograde flow in patients with acute ischemic stroke: preliminary experience and short term follow-up results.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Feasibility Studies; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Intracranial Hemorrhages; Male; Middle Aged; Stroke; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator | 2012 |
Intravenous tirofiban with intra-arterial urokinase and mechanical thrombolysis in stroke: preliminary experience in 11 cases.
Topics: Adult; Aged; Aged, 80 and over; Carotid Stenosis; Catheterization; Combined Modality Therapy; Female; Heparin; Humans; Infarction, Middle Cerebral Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Intracranial Hemorrhages; Male; Middle Aged; Risk; Severity of Illness Index; Stroke; Thrombolytic Therapy; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator | 2005 |